Artiva Biotherapeutics In... (ARTV)

3.86

-0.29 (-6.99%)

At close: Mar 03, 2025, 3:59 PM

3.92

1.55%

After-hours: Mar 03, 2025, 04:00 PM EST

Artiva Biotherapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20
Net Income	-28.72M	-58.79M	-71.83M	-17.99M
Depreciation & Amortization	2.27M	1.16M	248K	73K
Stock-Based Compensation	7.05M	6.58M	4.31M	297K
Other Working Capital	-27.36M	-2.38M	28.92M	249K
Other Non-Cash Items	251K	n/a	18.55M	-278K
Deferred Income Tax	n/a	n/a	n/a	n/a
Change in Working Capital	-28.28M	-3.87M	33.41M	4.36M
Operating Cash Flow	-47.43M	-50.83M	-15.3M	-13.54M
Capital Expenditures	-3.26M	-6.3M	-1.72M	-284K
Acquisitions	n/a	n/a	n/a	n/a
Purchase of Investments	-49.52M	n/a	n/a	n/a
Sales Maturities Of Investments	26.8M	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a
Investing Cash Flow	-25.98M	-6.3M	-1.72M	-284K
Debt Repayment	n/a	n/a	n/a	3M
Common Stock Repurchased	-12K	-5K	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	24.4M	-1.26M	152.75M	34.18M
Financial Cash Flow	24.39M	-1.26M	152.75M	37.4M
Net Cash Flow	-49.01M	-58.39M	135.73M	23.57M
Free Cash Flow	-50.69M	-57.13M	-17.03M	-13.82M